|
|  | |||
|
 |
home about contact disclaimer links member-login |
| |
 | ||||
 | ||||
 | ||||
 | ||||
 | ||||
 | ||||
   | ||||
 | |||||||||||||||||||
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
professionals · studies · ovarian.html | |
|
|
|
|
| |
|
Studies on Ovarian Carcinoma Whole body hyperthermia: Clinical phase II trail of combined thermochemotherapy (whole body hyperthermia plus Carboplatin/Ifosfamide) in platin-therapy refractory or relapsed ovarian cancer. Coordination: Prof. Dr. med. S. Hegewisch-Becker Abt. für Onkologie und Hämatologie Universitätsklinik Eppendorf Hamburg Tel. +49-40-42803 3971 Whole body hyperthermia : Clinical phase II trail to evaluate toxicity and effect of thermochemotherapy with Mito-mycin/Ifosfamide/Cisplatin (MIC) as a third line therapy of second line (MIC-alone) pro-gressive ovarian carcinoma Coordination: Prof. Dr. med. K. Bremer Klinik für Hämatologie und Onkologie Augusta-Kranken-Anstalt Bochum Tel: +49-0234-517-2430 Whole body hyperthermia : A randomized phase II/III trial comparing Carboplatin-Ifosfamide (IC)-chemotherapy vs. IC-chemotherapy combined with extreme whole body hyperthermia in patients with recurrence of epithelial ovarian carcinoma: DOLPHIN-1 Coordination: Prof. Dr. med. H. Sommer I. Frauenklinik Onkologie II Ludwig-Maximilian-Universität Tel. +49-89-5160-4276 | |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |